Sublingual fentanyl for refractory episodic acute dyspnea in patients with advanced chronic obstructive pulmonary disease (COPD): A real-world study

References

• Sundh J, Ekstrom M. Persistent disabling breathlessness in chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis. 2016;11:2805–2812. [published Online First: 2016/11/24] doi:10.2147/COPD.S119992.
   Google Scholar
• Ioanna T, Kocks J, Tzanakis N, et al. Factors that influence disease-specific quality of life or health status in patients with COPD: a systematic review and meta-analysis of Pearson correlations. Prim Care Respir J. 2011;20(3):257–268. doi:10.4104/pcrj.2011.00029.
   Google Scholar
• Miravitlles M, Ribera A. Understanding the impact of symptoms on the burden of COPD. Respir Res. 2017;18(1). doi:10.1186/s12931-017-0548-3.
   Google Scholar
• Simon ST, Weingartner V, Higginson IJ, et al. I can breathe again!" Patients’ Self-management strategies for episodic breathlessness in advanced disease, derived from qualitative interviews. J Pain Symptom Manage. 2016;52(2):228–234. doi:10.1016/j.jpainsymman.2016.02.016.
   Google Scholar
• Reijnders T, Schuler M, Wittmann M, et al. The impact of disease-specific fears on outcome measures of pulmonary rehabilitation in patients with COPD. Respir Med. 2019;146:87–95. doi:10.1016/j.rmed.2018.12.004.
   Google Scholar
• Hutchinson A, Pickering A, Williams P, Bland JM, Johnson MJ. Breathlessness and presentation to the emergency department: a survey and clinical record review. BMC Pulm Med. 2017;17(1):53. doi:10.1186/s12890-017-0396-4.
   Google Scholar
• Johnson MJ, Yorke J, Hansen-Flaschen J, et al. Towards an expert consensus to delineate a clinical syndrome of chronic breathlessness. Eur Respir J. 2017;49(5):1602277. doi:10.1183/13993003.02277-2016.
   Google Scholar
• Marciniuk DD, Goodridge D, Hernandez P, et al. Managing dyspnea in patients with advanced chronic obstructive pulmonary disease: A Canadian thoracic society clinical practice guideline. Can Respir J. 2011;18(2):1–10.
   Google Scholar
• Nici L, Mammen MJ, Charbek E, et al. Pharmacologic management of chronic obstructive pulmonary disease. An official American thoracic society clinical practice guideline. Am J Respir Crit Care Med. 2020;201(9):e56–e69. [published Online First: 2020/04/15] doi:10.1164/rccm.202003-0625ST.
   Google Scholar
• Parikh N, Goskonda V, Chavan A, Dillaha L. Pharmacokinetics and dose proportionality of fentanyl sublingual spray: a single-dose 5-way crossover study. Clin Drug Investig. 2013;33(6):391–400. doi:10.1007/s40261-013-0079-8.
   Google Scholar
• Taylor DR. Single-dose fentanyl sublingual spray for breakthrough cancer pain. Clin Pharmacol. 2013;5:131–141. [published Online First: 2013/08/01] doi:10.2147/CPAA.S26649.
   Google Scholar
• Doulton B. Pharmacologic management of adult breakthrough cancer pain. Can Fam Physician. 2014; Dec60(12):1111-4, e585-9.
   Google Scholar
• Gauna AA, Kang SK, Triano ML, et al. Oral transmucosal fentanyl citrate for dyspnea in terminally ill patients: an observational case series. J Palliat Med. 2008;11(4):643–648. [published Online First: 2008/05/06] doi:10.1089/jpm.2007.0161.
   Google Scholar
• Iupati S, Bridge R, Allan S, et al. Intranasal fentanyl versus placebo for treatment of episodic breathlessness in hospice patients with advanced nonmalignant diseases. J Pain Symptom Manage. 2021;61(5):1035–1041. [published Online First: 2020/11/14] doi:10.1016/j.jpainsymman.2020.11.003.
   Google Scholar
• Jensen D, Alsuhail A, Viola R, et al. Inhaled fentanyl citrate improves exercise endurance during high-intensity constant work rate cycle exercise in chronic obstructive pulmonary disease. J Pain Symptom Manage. 2012;43(4):706–719. [published Online First: 2011/12/16] doi:10.1016/j.jpainsymman.2011.05.007.
   Google Scholar
• Hui D, Kilgore K, Frisbee-Hume S, et al. Effect of Prophylactic Fentanyl Buccal Tablet on Episodic Exertional Dyspnea: A Pilot Double-Blind Randomized Controlled Trial. J Pain Symptom Manage. 2017;54(6):798–805. doi:10.1016/j.jpainsymman.2017.08.001.
   Google Scholar
• Hui D, Hernandez F, Larsson L, et al. Prophylactic Fentanyl Sublingual Spray for Episodic Exertional Dyspnea in Cancer Patients: A Pilot Double-Blind Randomized Controlled Trial. J Pain Symptom Manage. 2019;58(4):605–613. doi:10.1016/j.jpainsymman.2019.06.024.
   Google Scholar